Dr. Josep Redón i Mas

Investigador Principal
Grupo de Estudio de Riesgo Cardiometabólico y Renal

Presentación

El Dr. Redón cursa sus estudios en la Facultad de Medicina de la Universitat de València (1974), doctorándose en esta Universidad en 1985. Desde 2006 es Catedrático de Medicina Interna de Facultad de Medicina de la Universitat de València y Jefe de Servicio de Medicina Interna del Hospital Clínico de Valencia desde 1995.

Su actividad investigadora se ha realizado en paralelo a su actividad clínica poniendo en práctica una investigación traslacional en el campo de la Hipertensión Arterial y Riesgo Cardiovascular. Investigador principal y participante en más de 40 proyectos competitivos nacionales e internacionales. Ha cursado un Fellowship in Hypertension en el Departamento de Nefrología e Hipertensión de la Northwestern University (Prof. D Batlle) en Chicago y cuenta con estancias en el Departamento de Epidemiología y Medicina Preventiva de la Loyola University.

Está muy involucrado con las principales Sociedades Científicas de Hipertensión nacionales e internacionales. Ha sido Presidente de la Sociedad Española de Hipertensión, Presidente y Officer at Large de la European Society of Hipertensión y Fellow del Council for High Blood Pressure, American Heart Association. Miembro de Honor de las Sociedades de Hipertensión de Portugal, Bulgaria, Rumanía, España y de la Sociedad Latino-Americana (LASH). Entre otros méritos, destaca su participación como evaluador de la  Agencia Nacional de Evaluación y Prospectiva (ANECA) de la Secretaría de Estado de Universidades.

Dentro de la actividad Editorial es Miembro del Editorial Board de revistas indexadas en el campo de hipertensión, editor asociado del Journal of Hypertension, revisor de revistas del campo cardiovascular y de Medicina Interna y autor de numerosas editoriales y artículos de revisión por invitación. Cuenta con 560 publicaciones en revistas Indexadas, un total de 52407 citas y un factor de impacto acumulado superior a 1.100.

Recientemente ha sido galardonado con el título de Doctor Honoris Causa por la Universidad Carol Davila, Bucarest, y ha recibido el Premio a la Excelencia Sanitaria del Instituto Europeo de Salud y Bienestar Social.

Dr. Josep Redón i Mas
Investigador
Principal
Dr. Josep Redón i Mas

josep.redon@uv.es

Publicaciones
A comprehensive urban programme to reduce energy poverty and its effects on health and wellbeing of citizens in six European countries: study protocol of a controlled trial. Stevens M, Raat H, Ferrando M, Vallina B, Lucas R, Middlemiss L, Redon J, Rocher E, van Grieken A. BMC Public Health. 2022 Aug 19;22(1):1578. doi: 10.1186/s12889-022-13968-2. PMID: 35986259

Angiotensin receptor blockers evaluated by office and home blood pressure measurements. TeleHBPM Study. Barroso Weimar Kunz Sebba, Brandao AA, Valverde de Oliveira Vitorino P, Diogenes de Magalhaes Feitosa A, Costa Duarte Barbosa E, Dischinger Miranda R, Redon J, Camafort-Babkowski M, Coca A, Mota Gomes MA. Arquivos Brasileiros de Cardiologia. 2022 May 9;118(6):1069-1082. doi: 10.36660/abc.20210504. PMID: 35544853

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk. Bohm M, Schumacher H, Werner C, Teo K, Lonn E, Mahfoud F, Speer T, Mancia G, Redon J, Schmieder R, Sliwa K, Marx N, Weber M, Laufs U, Williams B, Yusuf S, Mann J. Cardiovascular Diabetology. 2022 Jan 20;21(1):12. doi: 10.1186/s12933-021-01429-w. PMID: 35057807

Association of single and joint metals with albuminuria and estimated glomerular filtration longitudinal change in middle-aged adults from Spain: The Aragon workers health study. Grau-Perez M, Domingo-Relloso A, Garcia-Barrera T, Gomez-Ariza J, Leon-Latre M, Casasnovas J, Moreno-Franco B, Laclaustra M, Guallar E, Navas-Acien A, Pastor-Barriuso R, Redon J, Tellez-Plaza M. Environmental Pollution. 2022 Dec 9;318:120851. doi: 10.1016/j.envpol.2022.120851. PMID: 36509352

Biofluid specificity of long non-coding RNA profile in hypertension: relevance of exosomal fraction. Riffo-Campos AL, Perez-Hernandez J, Martinez-Arroyo O, Ortega A, Flores-Chova A, Redon J, Cortes R. International Journal of Molecular Sciences. 2022 May 6;23(9):5199. doi: 10.3390/ijms23095199. PMID: 35563588

Exosomal and plasma non-coding RNA signature associated with urinary albumin excretion in hypertension. Riffo-Campos A, Perez-Hernandez J, Ortega A, Martinez-Arroyo O, Flores-Chova A, Redon J, Cortes R. International Journal of Molecular Sciences. 2022 Jan 13;23(2):823. doi: 10.3390/ijms23020823. PMID: 35055008

Gene-environment interaction analysis of redox-related metals and genetic variants with plasma metabolic patterns in a general population from Spain: the Hortega Study. Galvez-Fernandez M, Sanchez-Saez F, Domingo-Relloso A, Rodriguez-Hernandez Z, Tarazona S, Gonzalez-Marrachelli V, Grau-Perez M, Morales-Tatay J, Amigo N, Garcia-Barrera T, Gomez-Ariza J, Chaves F, Garcia-Garcia A, Melero R, Tellez-Plaza M, Martin-Escudero J, Redon J, Monleon D. Redox Biology. 2022 Jun;52:102314. doi: 10.1016/j.redox.2022.102314. PMID: 35460952

Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain. Delgado-Velandia M, Gonzalez-Marrachelli V, Domingo-Relloso A, Galvez-Fernandez M, Grau-Perez M, Olmedo P, Galan I, Rodriguez-Artalejo F, Amigo N, Briongos-Figuero L, Redon J, Martin-Escudero J, Monleon-Salvado D, Tellez-Plaza M, Sotos-Prieto M. International Journal of Behavioral Nutrition and Physical Activity. 2022 Jan 27;19(1):8. doi: 10.1186/s12966-021-01219-3. PMID: 35086546

Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community. Diaz J, Martinez F, Calderon JM, Fernandez A, Sauri I, Uso R, Trillo JL, Redon J, Forner MJ. ESC Heart Failure. 2022 Sep 16. doi: 10.1002/ehf2.14124. PMID: 36111519

Insights from matched office and ambulatory blood pressure in youth: clinical relevance. Lurbe E, Redon J, Alvarez J, Grau-Perez M, Martinez F, Mancia G. Hypertension. 2022 Mar 29;101161HYPERTENSIONAHA12218993. doi: 10.1161/HYPERTENSIONAHA.122.18993. PMID: 35345885

Lipoprotein profiles of fat distribution and its association with insulin sensitivity. Wei D, Marrachelli V, Melgarejo J, Liao C, Janssens S, Verhamme P, Vanassche T, Van Aelst L, Monleon D, Redon J, Zhang Z. Frontiers in Endocrinology. 2022 Oct 25;13:978745. doi: 10.3389/fendo.2022.978745. PMID: 36387872

Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study. Galvez-Fernandez M, Rodriguez-Hernandez Z, Grau-Perez M, Chaves F, Garcia-Garcia A, Amigo N, Monleon D, Garcia-Barrera T, Gomez-Ariza J, Briongos-Figuero L, Perez-Castrillon J, Redon J, Tellez-Plaza M, Martin-Escudero J. Free Radical Biology & Medicine. 2022 Nov 9;S0891-5849(22)00969-8. doi: 10.1016/j.freeradbiomed.2022.11.007. PMID: 36370960

New insights of cardiovascular and renal protection in diabetic chronic kidney disease with finerenone. Redon J. Cardiovascular Research. 2022 Mar 25;118(5):e36-e37. doi: 10.1093/cvr/cvac024. PMID: 35333317

Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status. Calderon J, Martinez F, Fernandez A, Sauri I, Diaz J, Uso R, Trillo J, Redon J, Forner M. Scientific reports. 2022 Apr 12;12(1):6123. doi: 10.1038/s41598-022-10164-5. PMID: 35414001

Real-world data of anticoagulant treatment in non-valvular atrial fibrillation. Calderon J, Martinez F, Diaz J, Fernandez A, Sauri I, Uso R, Trillo J, Vela S, Bea C, Redon J, Forner M. Frontiers In Cardiovascular Medicine. 2022 Jan 21;8:733300. doi: 10.3389/fcvm.2021.733300. PMID: 35127843

Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients. Olea B, Albert E, Torres I, Amat P, Remigia M, Gozalbo-Rovira R, Rodriguez-Diaz J, Buesa J, Blasco M, Redon J, Signes-Costa J, Navarro D. Journal of Clinical Virology. 2021 Sep;142:104943. doi: 10.1016/j.jcv.2021.104943. PMID: 34391981

Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: the LipoLab Study.. Pallares-Carratala V, Quesada J, Orozco-Beltran D, Amigo-Grau N, Lopez-Pineda A, Fernandez Gimenez A, Gil-Guillen V, Correig X, Masana L, Monleon Salvado D, Redón Mas J, Pascual R, Carratala-Munuera C. International Journal of Clinical Practice. 2021 Jan;75(1):e13610. doi: 10.1111/ijcp.13610. PMID: 32648987

Anthropometric indicators as a tool for diagnosis of obesity and other health risk factors: a literature review. Piqueras P, Ballester A, Dura-Gil J, Martinez-Hervas S, Redon J, Real J. Frontiers in Psychology. 2021 Jul 9;12:631179. doi: 10.3389/fpsyg.2021.631179. PMID: 34305707

Arsenic, cadmium, and selenium exposures and bone mineral density-related endpoints: The Hortega study. Galvez-Fernandez M, Grau-Perez M, Garcia-Barrera T, Ramirez-Acosta S, Gomez-Ariza J, Perez-Gomez B, Galan-Labaca I, Navas-Acien A, Redon J, Briongos-Figuero L, Duenas-Laita A, Perez-Castrillon J, Tellez-Plaza M, Martin-Escudero J. Free Radical Biology & Medicine. 2021 Jan;162:392-400. doi: 10.1016/j.freeradbiomed.2020.10.318. PMID: 33137469

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM, FIGARO-DKD Investigators. New England Journal of Medicine. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. PMID: 34449181

Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke. Boehm M, Schumacher H, Teo KK, Lonn EM, Lauder L, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S, Mann JF, Mahfoud F. Journal of Hypertension. 2021 Aug 1;39(8):1602-1610. doi: 10.1097/HJH.0000000000002822. PMID: 34188004

Cardiovascular system in the sars-CoV-2: impact of therapies. Redon J. Journal of Hypertension. 2021 Jul 1;39(7):1306-1308. doi: 10.1097/HJH.0000000000002860. PMID: 34074967

Cost of Type 2 diabetes patients with chronic kidney disease based on real-world data: an observational population-based study in Spain. Uso-Talamantes R, Gonzalez-de-Julian S, Diaz-Carnicero J, Sauri-Ferrer I, Trillo-Mata J, Carrasco-Perez M, Navarro-Perez J, Gorriz J, Vivas-Consuelo D, Redon J. International Journal of Environmental Research and Public Health. 2021 Sep 18;18(18):9853. doi: 10.3390/ijerph18189853. PMID: 34574782

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes. Nunez-Gil I, Fernandez-Ortiz A, Maroud Eid C, Huang J, Romero R, Becerra-Munoz V, Uribarri A, Feltes G, Trabatoni D, Fernandez-Rozas I, Viana-Llamas M, Pepe M, Cerrato E, Bertaina M, Capel Astrua T, Alfonso E, Castro-Mejia A, Raposeiras-Roubin S, D’Ascenzo F, Espejo Paeres C, Signes-Costa J, Bardaji A, Fernandez-Perez C, Marin F, Fabregat-Andres O, Akin I, Estrada V, Macaya C. Cardiology Journal. 2021 Feb 11;42(6):700-710. doi: 10.1093/eurheartj/ehaa943. PMID: 33351892

Genetic variation and urine cadmium levels: ABCC1 effects in the Strong Heart Family Study. Grau-Perez M, Voruganti V, Balakrishnan P, Haack K, Goessler W, Franceschini N, Redon J, Cole S, Navas-Acien A, Tellez-Plaza M. Environmental pollution. 2021 Feb 11;276:116717. doi: 10.1016/j.envpol.2021.116717. PMID: 33640655

Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. NCD Risk Factor Collaboration NCD. ELife. 2021 Mar 9;10:e60060. doi: 10.7554/eLife.60060. PMID: 33685583

Impact of obesity in kidney diseases. Kotsis V, Martinez F, Trakatelli C, Redon J. Nutrients. 2021 Dec 15;13(12):4482. doi: 10.3390/nu13124482. PMID: 34960033

Insights into glomerular filtration and albuminuria. Redon J, Selma-Soriano E, Cortes R. New England Journal of Medicine. 2021 Jul 29;385(5):477-478. doi: 10.1056/NEJMc2108129. PMID: 34320301

Prognostic value of diagnostic scales in community-acquired sepsis mortality at an emergency service. Prognosis in community-adquired sepsis. Clar J, Oltra MR, Benavent R, Pinto C, Ruiz A, Sanchez MT, Noceda J, Redon J, Forner MJ. BMC Emergency Medicine. 2021 Dec 18;21(1):161. doi: 10.1186/s12873-021-00532-1. PMID: 34922448

Rabphilin silencing causes dilated cardiomyopathy in a Drosophila model of nephrocyte damage. Selma-Soriano E, Casillas-Serra C, Artero R, Llamusi B, Navarro J, Redon J. Scientific Reports. 2021 Jul 27;11(1):15287. doi: 10.1038/s41598-021-94710-7. PMID: 34315987

Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort. Ruiz-Quintero M, Redón Mas J, Tellez-Plaza M, Cebrian-Cuenca A, Navarro Perez J, Menendez E, Perez-Navarro A, Fernandez-Gimenez A, Lopez-Pineda A, Quesada J, Pallares-Carratala V, Gil-Guillen V, Martín Moreno J, Bleda-Cano J, Carrascosa S, Carratala-Munuera C. Primary Care Diabetes. 2021 Feb;15(1):88-94. doi: 10.1016/j.pcd.2020.06.004. PMID: 32646765

Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk. Bohm M, Schumacher H, Teo K, Lonn E, Mahfoud F, Emrich I, Mancia G, Redon J, Schmieder R, Sliwa K, Lehrke M, Marx N, Weber M, Williams B, Yusuf S, Mann J. Journal of Hypertension. 2021 Apr 1;39(4):766-774. doi: 10.1097/HJH.0000000000002697. PMID: 33560052

SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with Coronavirus Disease 2019. Gimenez Quiles E, Albert Vicent E, Torres Fink I, Remigia Pellicer M, Alcaráz Soriana M, Galindo Puerto M, Blasco Cortes M, Solano Vercet C, Forner Giner M, Redón Mas J, Signes-Costa Miñana J, Navarro Ortega D. Journal of Medical Virology. 2021 Jan;93(1):375-382. doi: 10.1002/jmv.26213. PMID: 32579268

Small Rab GTPases in intracellular vesicle trafficking: the case of Rab3A/Raphillin-3a complex in the kidney. Martinez-Arroyo O, Selma-Soriano E, Ortega A, Cortes R, Redon J. International Journal of Molecular Sciences. 2021 Jul 18;22(14):7679. doi: 10.3390/ijms22147679. PMID: 34299299

Supervised Analysis for Phenotype Identification: The Case of Heart Failure Ejection Fraction Class. Lopez C, Holgado JL, Cortes R, Sauri I, Fernandez A, Calderon JM, Nuñez J, Redon J. Bioengineering. 2021 Jun 21;8(6):85. doi: 10.3390/bioengineering8060085. PMID: 34205745

Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease. Martinez-Arroyo O, Ortega A, Redon J, Cortes R. Hypertension. 2021 Jan;77(1):28-38. doi: 10.1161/HYPERTENSIONAHA.120.16064. PMID: 33222549

Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis. Perez Hernandez J, Martínez Arroyo O, Ortega Gutiérrez A, Galera Martos M, Solis Salguero M, Chaves Martínez F, Redón Mas J, Forner Giner M, Cortés Vergaz R. Journal Of Nephrology. 2021 Aug;34(4):1157-1167. doi: 10.1007/s40620-020-00832-y. PMID: 32803682

Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension. Perez-Hernandez J, Riffo-Campos A, Ortega A, Martinez-Arroyo O, Perez-Gil D, Olivares D, Solaz E, Martinez F, Martinez-Hervas S, Chaves F, Redon J, Cortes R. Hypertension. 2021 Mar 3;77(3):960-971. doi: 10.1161/HYPERTENSIONAHA.120.16598. PMID: 33486986

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. NCD Risk Factor Collaboration. Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. PMID: 34450083

Acute kidney injury in heart failure: a population study. Holgado Sánchez J, Lopez Forte C, Fernández Giménez A, Saurí Ferrer M, Uso Talamantes R, Trillo Mata J, Vela Bernal S, Nuñez Villota J, Redón Mas J, Ruiz Hernandez A. Esc Heart Failure. 2020 Apr;7(2):415-422. doi: 10.1002/ehf2.12595. PMID: 32059081

Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease. Pichler G, Redon J, Martinez F, Solaz E, Calaforra O, Andres M, Lopez B, Diez J, Oberbauer R, Adlbrecht C, Karth G, Maceira A. Journal of Hypertension. 2020 Oct;38(10):2036-2042. doi: 10.1097/HJH.0000000000002504. PMID: 32890280

Chronic kidney disease as a cardiovascular risk factor. Carmena Rodriguez R, Ascaso Gimilio J, Redón Mas J. Journal of Hypertension. 2020 Nov;38(11):2110-2121. doi: 10.1097/HJH.0000000000002506. PMID: 32649622

Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia. Blasco Cortes M, Buesa Gomez J, Colomina Rodríguez F, Forner Giner M, Galindo Puerto M, Navarro Perez J, Noceda Bermejo J, Redón Mas J, Signes-Costa Miñana J, Navarro Ortega D. Journal Of Medical Virology. 2020 Oct;92(10):1799-1801. doi: 10.1002/jmv.25922. PMID: 32320082

Decreased Urinary Levels of SIRT1 as Non-Invasive Biomarker of Early Renal Damage in Hypertension. Martínez Arroyo O, Ortega Gutiérrez A, Galera Martos M, Solaz Moreno E, Martinez Hervas S, Redón Mas J, Cortés Vergaz R. International Journal of Molecular Sciences. 2020 Sep 2;21(17):6390. doi: 10.3390/ijms21176390. PMID: 32887498

Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants. NCD Risk Factor Collaboration. Lancet. 2020 Nov 7;396(10261):1511-1524. doi: 10.1016/S0140-6736(20)31859-6. PMID: 33160572

Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. Borghi C, Agabiti-Rosei E, Johnson R, Kielstein J, Lurbe Ferrer E, Mancia G, Redón Mas J, Stack A, Tsioufis K. European Journal of Internal Medicine. 2020 Oct;80:1-11. doi: 10.1016/j.ejim.2020.07.006. PMID: 32739239

Identifying poor cardiorespiratory fitness in overweight and obese children and adolescents by using heart rate variability analysis under resting conditions. Redon Lurbe P, Grassi G, Redón Mas J, Alvarez Pitti J, Lurbe Ferrer E. Blood Pressure. 2020 Feb;29(1):13-20. doi: 10.1080/08037051.2019.1700777. PMID: 31829032

Impact of Acute Hemoglobin Falls in Heart Failure Patients: A Population Study. López Zumel M, Holgado Sánchez J, Ferrandez Izquierdo A, Saurí Ferrer M, Uso Talamantes R, Trillo Mata J, Vela Bernal S, Bea Serrano C, Nuñez Villota J, Ferrer Albero A, Gamez Payá J, Ruiz Hernandez A, Redón Mas J. Journal of Clinical Medicine. 2020 Jun 15;9(6):1869. doi: 10.3390/jcm9061869. PMID: 32549339

National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries. NCD Risk Factor Collaboration. International Journal of Epidemiology. 2020 Feb 1;49(1):173-192. doi: 10.1093/ije/dyz099. PMID: 31321439

Nutraceuticals and blood pressure control: a European Society of Hypertension position document. Borghi C, Tsioufis K, Agabiti-Rosei E, Burnier M, Cicero A, Clement D, Coca A, Desideri G, Grassi G, Lovic D, LURBE FERRER E, Kahan T, Kreutz R, Jelakovic B, Polonia J, Redón Mas J, Van De Borne P, Mancia G. Journal of Hypertension. 2020 May;38(5):799-812. doi: 10.1097/HJH.0000000000002353. PMID: 31977574

Optimization of small RNA library preparation protocol from human urinary exosomes. Olivares Gazquez M, Perez Hernandez J, Perez Gil D, Chaves Martínez F, Redón Mas J, Cortés Vergaz R. Journal of Translational Medicine. 2020 Mar 18;18(1):132. doi: 10.1186/s12967-020-02298-9. PMID: 32188466

Pulmonary thrombosis in situ’: risk factors, clinic characteristics and long-term evolution. Fletcher-Sanfeliu D, Redon J, Garcia-Granero A, Frasson M, Barreira I, Martinez-Leon J, Garcia-Fuster M. Blood Coagulation & Fibrinolysis. 2020 Oct;31(7):469-475. doi: 10.1097/MBC.0000000000000949. PMID: 32833808

Rab-rabphilin system in injured human podocytes stressed by glucose overload and angiotensin II. Martínez Arroyo O, Ortega Gutiérrez A, Perez Hernandez J, Chaves Martínez F, Redón Mas J, Cortés Vergaz R. American Journal of Physiology. Renal Physiology. 2020 Aug 1;319(2):F178-F191. doi: 10.1152/ajprenal.00077.2020. PMID: 32567349

Rabphilin involvement in filtration and molecular uptake in Drosophila nephrocytes suggests a similar role in human podocytes. Selma Soriano E, Llamusi Troisi M, Fernandez Costa J, Ozimski L, Artero Allepuz R, Redón Mas J. Disease Models & Mechanisms. 2020 Sep 21;13(9):dmm041509. doi: 10.1242/dmm.041509. PMID: 32680845

Redefining hypertension in children and adolescents: A review of the evidence considered by the European Society of Hypertension and American Academy of Pediatrics guidelines.Stabouli S, Redón Mas J, Lurbe Ferrer E. Journal of Hypertension. 2020 Feb;38(2):196-200. doi: 10.1097/HJH.0000000000002247. PMID: 31584513

Repositioning of the global epicentre of non-optimal cholesterol. NCD Risk Factor Collaboration (NCD-RisC). Nature. 2020 Jun;582(7810):73-77. doi: 10.1038/s41586-020-2338-1. PMID: 32494083

Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.Böhm M, Schumacher H, Teo K, Lonn E, Mahfoud F, Ukena C, Mann J, Mancia G, Redón Mas J, Schmieder R, Sliwa K, Marx N, Weber M, Williams B, Yusuf S. European Heart Journal. 2020 Jan 7;41(2):231-238. doi: 10.1093/eurheartj/ehy808. PMID: 30590564

The influence of hemoglobin A1c levels on cardiovascular events and all-cause mortality in people with diabetes over 70 years of age. A prospective study. Orozco-Beltran D, Navarro Perez J, Cebrian-Cuenca A, Alvarez-Guisasola F, Caride-Miana E, Mora G, Quesada J, Lopez-Pineda A, Cardona-Llorens A, Redón Mas J, Gil-Guillen V, Ferrandez Izquierdo A, Carratala-Munuera C. Primary Care Diabetes. 2020 Dec;14(6):678-684. doi: 10.1016/j.pcd.2020.06.003. PMID: 32605878

Unraveling new factors associated with hypertension: the Mendelian randomization approach. Grau Pérez M, Redón Mas J. Journal of Hypertension. 2020 Jan;38(1):30-32. doi: 10.1097/HJH.0000000000002251. PMID: 31790017

Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Piepoli M, Abreu A, Albus C, Ambrosetti M, Brotons C, Catapano A, Corra U, Cosyns B, Deaton C, Graham I, Hoes A, Lochen M, Matrone B, Redón Mas J, Sattar N, Smulders Y, Tiberi M. European Journal of Preventive Cardiology. 2020 Jan;27(2):181-205. doi: 10.1177/2047487319893035. PMID: 31826679

Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials. Mancia G, Schumacher H, Bohm M, Mann J, Redón Mas J, Facchetti R, Schmieder R, Lonn E, Teo K, Yusuf S. Journal of Hypertension. 2020 Oct;38(10):2050-2058. doi: 10.1097/HJH.0000000000002567. PMID: 32694337

Proyectos
Referencia: EHDEN – OMOP
Título: EHDEN. Harmonization Fund Holder
Entidad Financiadora: European Commission (3rd Health Program)
Investigador principal: Josep Redón i Mas
Duración: 2022 – 2023
Presupuesto: 50.000,00 €
Referencia: 945097-WELLBASED
Título: WELLBASED. Improving health, wellbeing and equality by evidenced-based urban policies for tackling energy poverty
Entidad Financiadora: European Commission
Investigador principal: Josep Redón i Mas
Duración: 2021 – 2025
Presupuesto: 395.250,00 €
Referencia: PI19/01796
Título: Implicaciones experimentales y clinicas del complejo proteico rabphilin-rab en daño renal en la diabetes mellitus tipo 2
Entidad Financiadora: Instituto de Salud Carlos III – Cofinanciado FEDER
Investigador principal: Josep Redón i Mas
Duración: 2020 – 2022
Presupuesto: 196.020 €
Referencia: 780495-BigMedilytics
Título: Big Data for Medical Analytics
Entidad Financiadora: European Commission
Investigador principal: Josep Redón i Mas
Duración: 2018 – 2021
Presupuesto: 1062136,25
Referencia: BodyPass
Título: API-ecosystem for cross-sectorial exchange of 3D personal data
Entidad Financiadora: European Commission
Investigador principal: Josep Redón i Mas
Duración: 2018 – 2020
Presupuesto: 351937,5
Referencia: PT17/0005/0017
Título: Plataforma de Innovación
Entidad Financiadora: Instituto de Salud Carlos III – Cofinanciado FEDER
Investigador principal: Josep Redón i Mas
Duración: 2018 – 2021
Presupuesto: 38.985 €
Referencia: BigData@Heart
Título: Big Data for Better Hearts
Entidad Financiadora: European Commission
Investigador principal: Josep Redón i Mas
Duración: 2017 – 2022
Presupuesto: 386250
Referencia: PI16/01402
Título: Estudio experimental in vivo e in vitro y la aplicación clínica del impacto de las proteínas del complejo Rhabphilin-Rab en el desarrollo del daño renal y cardiovascular
Entidad Financiadora: Instituto de Salud Carlos III – Cofinanciado FEDER
Investigador principal: Josep Redón i Mas
Duración: 2017 – 2019
Presupuesto: 194.205 €
Referencia: PROMETEO/2016/084
Título: Innovación tecnológica en la evaluación del sistema nervioso simpático en adolescentes y adultos jóvenes obesos: papel en la estratificación del riesgo e intervención terapéutica
Entidad Financiadora: Conselleria de Educación, Cultura y Deporte
Investigador principal: Josep Redón i Mas
Duración: 2016 – 2019
Presupuesto: 246.190 €
Referencia: ADVANTAGE
Título: Managing Frailty. A comprehensive approach to promote a disability-free advanced age in Europe: the ADVANTAGE initiative
Entidad Financiadora: European Commission (3rd Health Program)
Investigador principal: Josep Redón i Mas, José Viña Ribes
Duración: 2016 – 2019
Presupuesto: 130005
+ Información
Impact of ESH and AAP hypertension guidelines for children and adolescents on office and ambulatory blood pressure-based classifications. Lurbe E, Torró I, Álvarez J, Aguilar F, Mancia G, Redon J, Redon P. Journal of Hypertension. 2019 Dec;37(12):2414-2421. doi: 10.1097/HJH.0000000000002229. PMID: 31688292

2018 ESC/ESH Guidelines for the management of arterial. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I. Kardiologia Polska. 2019;77(2):71-159. doi: 10.5603/KP.2019.0018. PMID: 30816983

Redefining hypertension in children and adolescents: A review of the evidence considered by the European Society of Hypertension and American Academy of Pediatrics guidelines.Stabouli S, Redón Mas J, Lurbe Ferrer E. Journal of Hypertension. 2020 Feb;38(2):196-200. doi: 10.1097/HJH.0000000000002247. PMID: 31584513

Título: Evaluación cardiometabólica y adrenérgica en el sujeto obeso sano joven
Doctorando: Ruiz Hernández, Adrián
Director: Forner Giner, Mª José; Redón i Mas, Josep
Fecha: 28/04/2022
Universidad: Universitat de València

Título: Valor pronóstico de los cambios en la rigidez arterial en la hipertensión arterial esencial
Doctorando: Calaforra Juan, Oscar
Director: Redón Mas, Josep; Forner Giner, María José; Martínez García, Fernando
Fecha: 28/07/2020
Universidad: Universitat de València

Título: Sistema de biosensado fotónico para la detección de trombina, alérgenos y patógenos. Funcionalización química de chips fotónicos basados en estructuras de anillos resonantes
Doctorando: Sánchez Sánchez, Carlos
Director: Martí Sendra, Javier; Redón Mas, Josep; Peransí Llopis, Sergio Manuel
Fecha: 15/11/2019
Universidad: Universitat Politècnica de València

Título: Estudio de la evolución del sellado distal ilíaco en el tratamiento endovascular de la aorta abdominal
Doctorando: Bargay Juan, Pau
Director: Redon Mas, Josep; Plaza Martínez, Ángel
Fecha: 25/02/2019
Universidad: Universitat de València

Título: Monitorización del manejo de sepsis para la identificación de flujos asistenciales y su impacto en la evolución de los pacientes. El diagnóstico precoz de sepsis en urgencias
Doctorando: Clar Bononad, Jorge
Director: Oltra Sempere, Mª Rosa; Redón i Mas, Josep
Fecha: 10/02/2022
Universidad: Universitat de València